Article

Diamond Nanocrystal Laser as a New Cancer Therapy

Author(s):

Process improves the accuracy of cancer treatments.

Process improves the accuracy of cancer treatments.

Scientists have created a hypersensitive nanoprobe that targets cancer cells with a localized laser.

Targeting cancer cells in treatments, while making sure that they do not affect other cells, can at times present a significant challenge. Scientists at the Institute of Atomic and Molecular Sciences at the Academia Sinica, Taipei have modified a fluorescent diamond nanocrystal to specifically target cancer cells.

The team, led by Pei-Chang Tsai, attached gold nanoprods to the diamond nanocrystal. The effect from this process created a heating source with a very specific target, which is activated based on the temperature and magnetic field.

This study has improved the accuracy of cancer treatments. By using the diamond nanocrystal, scientists will be better able to monitor the amount of heat delivered to cancer cells, with less error.

This study was published in EPJ QT.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards